Vandana Singh
·
January 2, 2025
Benzinga
Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise capacity improvements.
read more
April 30, 2025
April 25, 2025
Barchart
January 3, 2025
April 11, 2025
Bloomberg